agilon health, inc. (NYSE:AGL – Get Free Report) CEO Steven Sell acquired 20,000 shares of agilon health stock in a transaction that occurred on Thursday, September 12th. The shares were purchased at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the purchase, the chief executive officer now directly owns 67,590 shares in the company, valued at $227,102.40. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
agilon health Price Performance
Shares of AGL opened at $4.00 on Thursday. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 0.04. agilon health, inc. has a twelve month low of $3.07 and a twelve month high of $20.37. The stock has a market capitalization of $1.65 billion, a P/E ratio of -5.71 and a beta of 0.54. The company has a 50 day moving average of $5.26 and a 200-day moving average of $5.55.
agilon health (NYSE:AGL – Get Free Report) last released its earnings results on Tuesday, August 6th. The company reported ($0.07) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.07). agilon health had a negative net margin of 5.57% and a negative return on equity of 29.91%. The business had revenue of $1.48 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter last year, the firm earned ($0.04) earnings per share. The firm’s revenue for the quarter was up 38.7% compared to the same quarter last year. As a group, equities research analysts forecast that agilon health, inc. will post -0.32 EPS for the current fiscal year.
Institutional Trading of agilon health
Analyst Upgrades and Downgrades
Several research firms have weighed in on AGL. Evercore ISI increased their target price on shares of agilon health from $5.50 to $7.00 and gave the stock an “in-line” rating in a report on Tuesday, July 9th. Truist Financial raised their price objective on agilon health from $6.40 to $6.50 and gave the stock a “hold” rating in a research note on Friday, May 24th. Royal Bank of Canada reissued an “outperform” rating and issued a $8.00 target price on shares of agilon health in a research note on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft dropped their price target on agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a research report on Friday, August 9th. Finally, Robert W. Baird assumed coverage on agilon health in a research report on Thursday, May 30th. They issued a “neutral” rating and a $6.00 price objective for the company. One research analyst has rated the stock with a sell rating, fourteen have issued a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, agilon health currently has a consensus rating of “Hold” and an average target price of $8.57.
Check Out Our Latest Stock Analysis on AGL
agilon health Company Profile
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Read More
- Five stocks we like better than agilon health
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- How Much Can You Make in Stocks in One Month?
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- This Is the Top Large-Cap Stock Insiders Are Buying
- What is a support level?
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.